Chiesi USA Inc., a Cary, N.C.-based subsidiary of Italy's Chiesi Farmaceutici SpA, confirmed its designation as a Delaware Public Benefit Corporation, joining a small group of pharma companies that have committed to the purpose, accountability and transparency principles required for the status.